Reme-D Inc.
PrivateLast Round
Early Funding
Jul 24, 2026
Total Funding Raised
$3.36M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Reme-D Inc. is a biotechnology company that develops and manufactures affordable, room-temperature-stable molecular diagnostic kits for human and animal diseases in underserved regions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Reme-D Inc. Comparables
Compare Reme-D Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vitrosens Biotechnology | 78% | |
| Rapidemic | 78% | |
| Molbio Diagnostics | 73% |
Reme-D Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jul 24, 2026 | ||||
| Grant | Apr 8, 2026 | ||||
| Early Funding | Apr 2, 2026 | ||||
| Seed | Oct 1, 2025 | ||||
| Accelerator | Mar 14, 2024 | ||||
Grant | Mar 8, 2024 |
Reme-D Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Techstars | Accelerator |
| Ministry of Communications and Information Technology, Saudi Arabia | Grant |
| Global Innovation Fund | Early Funding |
| Africa Health Ventures | Early Funding |
| Misk Foundation | Grant |
| Oman Technology Fund | Seed |
| Bayer Cares Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2026
Grew 19% QoQ, from 32 to 38 employees.
- Jul 24, 2026
$1.45M raised led by Anara Impact Capital.
Recent news
Latest coverage and updates
- signs_new_clientJul 21, 2026
Reme D Inc signed new client World Health Organization International on Jul 1st '26.
- receives_financingJul 20, 2026
Reme D Inc received financing of $1.45M in Pre Series A on Jul 20th '26.
- receives_financingJun 15, 2026
Reme D Inc receives financing of $2M.
Reme-D Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Reme-D Inc.'s valuation, stock price, and market status.
Is Reme-D Inc. a public or private company?
Reme-D Inc. is a private company.
What is the current stock price of Reme-D Inc.?
Reme-D Inc. is a private company with no public stock price. Caplight tracks Reme-D Inc.'s secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Reme-D Inc. worth (valuation)?
Valuation information for Reme-D Inc. is not publicly available.
Can I buy Reme-D Inc. stock?
Reme-D Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Reme-D Inc.'s last funding round?
Reme-D Inc.'s most recent funding round was Grant on April 8, 2026.
Who are the main investors in Reme-D Inc.?
Key investors in Reme-D Inc. include Techstars, Global Innovation Fund.
Will Reme-D Inc. IPO soon?
No public IPO plans have been announced for Reme-D Inc..
How can I track Reme-D Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Reme-D Inc.'s secondary market activity and sign up for updates.